nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile
|
Piccardo, Arnoldo |
|
2018 |
46 |
3 |
p. 766-775 |
artikel |
2 |
Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
|
Krebs, Simone |
|
2018 |
46 |
3 |
p. 677-685 |
artikel |
3 |
Bombardieri E, Seregni E, Evangelista L, Chiesa C, Chiti A (Eds.) Clinical Applications of Nuclear Medicine Targeted Therapy. Springer International Publishing Switzerland 2018. ISBN 978-3-319-63067-0
|
Mansi, Luigi |
|
2018 |
46 |
3 |
p. 790 |
artikel |
4 |
Christopher E. Comstock, Christiane Kuhl (Eds.): Abbreviated MRI of the Breast: A Practical Guide
|
Mansi, Luigi |
|
2018 |
46 |
3 |
p. 789 |
artikel |
5 |
Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study
|
Unterrainer, Marcus |
|
2018 |
46 |
3 |
p. 580-590 |
artikel |
6 |
Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI
|
Reinert, Christian Philipp |
|
2018 |
46 |
3 |
p. 776-787 |
artikel |
7 |
Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis
|
Treglia, Giorgio |
|
2018 |
46 |
3 |
p. 751-765 |
artikel |
8 |
Early 18F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma
|
Leroy-Freschini, Benjamin |
|
2019 |
46 |
3 |
p. 686-695 |
artikel |
9 |
Ectopic corticotropin-releasing hormone syndrome caused by pancreatic neuroendocrine tumor localized by 68Ga-DOTATATE PET/CT
|
Hou, Guozhu |
|
2018 |
46 |
3 |
p. 788 |
artikel |
10 |
18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
|
Humbert, Olivier |
|
2019 |
46 |
3 |
p. 558-568 |
artikel |
11 |
Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma
|
Lundemann, Michael |
|
2018 |
46 |
3 |
p. 603-613 |
artikel |
12 |
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma
|
Lohmann, Philipp |
|
2018 |
46 |
3 |
p. 591-602 |
artikel |
13 |
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
|
Kong, Grace |
|
2018 |
46 |
3 |
p. 718-727 |
artikel |
14 |
Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation
|
Aalbersberg, E. A. |
|
2018 |
46 |
3 |
p. 696-703 |
artikel |
15 |
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
|
Law, Ian |
|
2018 |
46 |
3 |
p. 540-557 |
artikel |
16 |
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
|
Del Prete, Michela |
|
2018 |
46 |
3 |
p. 728-742 |
artikel |
17 |
PET-based prognostic survival model after radiotherapy for head and neck cancer
|
Castelli, Joël |
|
2018 |
46 |
3 |
p. 638-649 |
artikel |
18 |
Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity
|
Roodakker, Kenney Roy |
|
2018 |
46 |
3 |
p. 569-579 |
artikel |
19 |
Regulation of human brown adipose tissue by adenosine and A2A receptors – studies with [15O]H2O and [11C]TMSX PET/CT
|
Lahesmaa, Minna |
|
2018 |
46 |
3 |
p. 743-750 |
artikel |
20 |
Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
|
Królicki, Leszek |
|
2018 |
46 |
3 |
p. 614-622 |
artikel |
21 |
Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours
|
Zwan, W. A. van der |
|
2018 |
46 |
3 |
p. 704-717 |
artikel |
22 |
The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma
|
Giammarile, Francesco |
|
2018 |
46 |
3 |
p. 623-637 |
artikel |
23 |
The evolving Editorial Board
|
Chiti, Arturo |
|
2019 |
46 |
3 |
p. 539 |
artikel |
24 |
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage
|
Cappelli, Alberta |
|
2018 |
46 |
3 |
p. 661-668 |
artikel |
25 |
Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy
|
Guedj, Eric |
|
2018 |
46 |
3 |
p. 537-538 |
artikel |
26 |
Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma
|
Chen, Yu-Hung |
|
2018 |
46 |
3 |
p. 650-660 |
artikel |
27 |
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience
|
Bourien, Héloïse |
|
2018 |
46 |
3 |
p. 669-676 |
artikel |